Vascular Web Logo

SVS  SVS Foundation
A A A
VascularWeb

 PS216. Angiogenesis Inhibitor Sunitinib Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysm

​Yasunori Iida2, Baohui Xu1, Xiaolei Hu1, Vinca Chow1, Richard Yuan1, Mary Gerritsen1, Hitoshi Ogino2, Ronald L. Dalman1
1Stanford University School of Medicine, Stanford, CA; 2Tokyo Medical University, Tokyo, Japan.

OBJECTIVES: Mural angiogenesis is a prominent pathologic feature in abdominal aortic aneurysm (AAA) disease. We evaluated the effect of sunitinib, an FDA-approved angiogenesis inhibitor, on the formation and progression of experimental AAA.

METHODS: AAAs were created via by intraaortic PPE infusion in 10-wk-old male C57BL/6 mice. Oral sunitinib (or vehicle alone) was administered either from 1) 3 days prior to PPE infusion, or 2) 5 days thereafter  ̶  until sacrifice. Aortic diameter was serially monitored via ultrasound, and aortae harvested for histopathology at 14 days.

RESULTS: AAA (defined as ≥50% diameter increase) developed in all vehicle-treated mice (n=4-7 mice). Sunitinib treatment initiated prior to PPE infusion at 4, 20 or 100 mg/kg/day prevented AAA formation (n=3-7 mice). Additionally, sunitinib initiated after PPE infusion at 4 or 100 mg/kg stabilized and reduced AAA diameter, respectively, compared to immediate pre-treatment diameter. Sunitinib preserved aortic medial elastin and smooth muscle cellularity, while reducing medial/adventitial angiogenesis and monocytes/macrophages density.

CONCLUSIONS: Sunitinib therapy suppresses AAA formation, as well as stabilizing or regressing aortic diameter in existing aneurysms in a dose-dependent fashion. Similar strategies may prove effective in suppressing or stabilizing early AAA disease.

AUTHOR DISCLOSURES: V. Chow, Nothing to disclose; R. L. Dalman, Nothing to disclose; M. Gerritsen, Nothing to disclose; X. Hu, Nothing to disclose; Y. Iida, Nothing to disclose; H. Ogino, Nothing to disclose; B. Xu, Nothing to disclose; R. Yuan, Nothing to disclose.

PS216.jpg

Posted April 2012

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320
Email: vascular@vascularsociety.org

Follow Us

YouTube

VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.